TA-DOTA

• UNSPSC Description:

  TA-DOTA is a radionuclide conjugate (RDC), which is capable of binding to a radionuclide. RDC has the ability to specifically target biomolecules and can be used in medical imaging or therapy[1].

• Target Antigen:

  Radionuclide-Drug Conjugates (RDCs)

• Type:

  Reference compound

• Related Pathways:

  Antibody-drug Conjugate/ADC Related

• Applications:

  Cancer-programmed cell death

• Field of Research:

  cancer

• Assay Protocol:

  https://www.medchemexpress.com/ta-dota.html

• Smiles:

  O=C(CN1CCN(CCN(CCN(CC1)CC(O)=O)CC(NCCNC(CCCCC2SSCC2)=O)=O)CC(O)=O)O

• Molecular Weight:

  634.81

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2451069-30-8